Montmed announced that it has resumed direct distribution and commercialization of SiteSmart®, regaining full control of the product’s strategic direction and market development activities. The transition strengthens Montmed’s ability to pursue new partnerships, accelerate market expansion, and further enhance the value of its proprietary SiteSmart® platform, which transforms pen needles from commodity delivery devices into clinically differentiated tools that support improved injection practices and better patient outcomes.
